Literature DB >> 31104103

The co-segregation of the MYL2 R58Q mutation in Chinese hypertrophic cardiomyopathy family and its pathological effect on cardiomyopathy disarray.

Kunlun Yin1, Yi Ma1, Hao Cui2, Yang Sun1, Bianmei Han1, Xuewen Liu1, Kun Zhao1, Wenke Li1, Jingjin Wang3, Hongyue Wang1, Shuiyun Wang4, Zhou Zhou5.   

Abstract

Hypertrophic cardiomyopathy (HCM), a major cause of sudden death in youth, is largely affected by genetic factors. The R58Q mutation in the MYL2 gene was identified in some HCM patients and was considered as a deleterious HCM mutation. However, the passing of R58Q between generations along with HCM symptoms was observed only in small families with only two or three members; thus, whether R58Q is as deleterious as previously claimed remains questionable. Here, we reported a large four-generation Chinese family, and found that R58Q existed in all six members with HCM and two healthy juveniles who had not yet developed HCM yet, and presumably in three deceased members who suffered from sudden death. In addition, we also found that compared with other mutations, R58Q had a more severe effect on the cellular level. Therefore, we confirmed that R58Q could be passed from generation to generation along with HCM symptoms and that it was indeed a deleterious mutation for HCM. However, further study is needed to identify additional factors that may determine the various symptoms shown in different family members within the same family.

Entities:  

Keywords:  Disorganization; Hypertrophic cardiomyopathy; MYL2 R58Q; Pathologic alteration; Segregation

Mesh:

Substances:

Year:  2019        PMID: 31104103     DOI: 10.1007/s00438-019-01578-4

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  31 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 2.  Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.

Authors:  Iacopo Olivotto; Giulia d'Amati; Cristina Basso; Albert Van Rossum; Monica Patten; Michele Emdin; Yigal Pinto; Benedetta Tomberli; Paolo G Camici; Michelle Michels
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

3.  Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.

Authors:  Jérôme Peyrou; Patricia Réant; Amélie Reynaud; Claire Cornolle; Marina Dijos; Caroline Rooryck-Thambo; Mathieu Landelle; Michel Montaudon; François Laurent; Raymond Roudaut; Stéphane Lafitte
Journal:  Int J Cardiovasc Imaging       Date:  2016-06-20       Impact factor: 2.357

4.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

5.  Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type.

Authors:  J Ghiso; M Haltia; F Prelli; J Novello; B Frangione
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

6.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

7.  Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.

Authors:  J Flavigny; P Richard; R Isnard; L Carrier; P Charron; G Bonne; J F Forissier; M Desnos; O Dubourg; M Komajda; K Schwartz; B Hainque
Journal:  J Mol Med (Berl)       Date:  1998-03       Impact factor: 4.599

8.  Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Authors:  Martin S Maron; Iacopo Olivotto; Andrey G Zenovich; Mark S Link; Natesa G Pandian; Jeffery T Kuvin; Stefano Nistri; Franco Cecchi; James E Udelson; Barry J Maron
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

9.  Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.

Authors:  Stellan Mörner; Pascale Richard; Elsadig Kazzam; Urban Hellman; Bernard Hainque; Ketty Schwartz; Anders Waldenström
Journal:  J Mol Cell Cardiol       Date:  2003-07       Impact factor: 5.000

10.  Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Authors:  Angharad M Roberts; James S Ware; Daniel S Herman; Sebastian Schafer; John Baksi; Alexander G Bick; Rachel J Buchan; Roddy Walsh; Shibu John; Samuel Wilkinson; Francesco Mazzarotto; Leanne E Felkin; Sungsam Gong; Jacqueline A L MacArthur; Fiona Cunningham; Jason Flannick; Stacey B Gabriel; David M Altshuler; Peter S Macdonald; Matthias Heinig; Anne M Keogh; Christopher S Hayward; Nicholas R Banner; Dudley J Pennell; Declan P O'Regan; Tan Ru San; Antonio de Marvao; Timothy J W Dawes; Ankur Gulati; Emma J Birks; Magdi H Yacoub; Michael Radke; Michael Gotthardt; James G Wilson; Christopher J O'Donnell; Sanjay K Prasad; Paul J R Barton; Diane Fatkin; Norbert Hubner; Jonathan G Seidman; Christine E Seidman; Stuart A Cook
Journal:  Sci Transl Med       Date:  2015-01-14       Impact factor: 17.956

View more
  2 in total

1.  Identification and genetic analysis of rare variants in myosin family genes in 412 Han Chinese congenital heart disease patients.

Authors:  Yunqian Zhang; Rui Peng; Hongyan Wang
Journal:  Mol Genet Genomic Med       Date:  2022-08-22       Impact factor: 2.473

2.  Integrated Multilayer Omics Reveals the Genomic, Proteomic, and Metabolic Influences of Histidyl Dipeptides on the Heart.

Authors:  Keqiang Yan; Zhanlong Mei; Jingjing Zhao; Md Aminul Islam Prodhan; Detlef Obal; Kartik Katragadda; Benjamin Doelling; David Hoetker; Dheeraj Kumar Posa; Liqing He; Xinmin Yin; Jasmit Shah; Jianmin Pan; Shesh Rai; Pawel Konrad Lorkiewicz; Xiang Zhang; Siqi Liu; Aruni Bhatnagar; Shahid P Baba
Journal:  J Am Heart Assoc       Date:  2022-06-22       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.